Form 13-F position report

CERO THERAPEUTICS HLDGS INC

Reported by SBI Securities Co Ltd

CERO CUSIP 71902K303 Manager CIK 0001851815

Reported 110 shares, down 5,413 (98.0%) from the prior quarter.

Reported value -75.8%; share count -98.0% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 110 Quarter-end amount reported
Reported value $80 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 331
2025-03-31 80
2025-06-30 0
2025-06-30 173
2025-09-30 92
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for CERO THERAPEUTICS HLDGS INC held by SBI Securities Co Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -18 (-100.0%) 0 $0 2026-02-03
Q3 2025 Unchanged 18 0 (0.0%) < 0.01% $92 2025-11-05
Q2 2025 New 18 +18 (0.0%) < 0.01% $173 2025-08-08
Q2 2025 Reduced 0 -110 (-100.0%) 0 $0 2025-08-08
Q1 2025 Reduced 110 -5,413 (-98.0%) < 0.01% $80 2025-05-02
Q4 2024 New 5,523 +5,523 (0.0%) < 0.01% $331 2025-02-06

Who else reported the position

15 managers reported CERO THERAPEUTICS HLDGS INC for Q1 2025.

Managers reporting CERO THERAPEUTICS HLDGS INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC New 312,000 +312,000 < 0.01% $227,760 1 qtr
Parallel Advisors LLC New 220,000 +220,000 < 0.01% $160,600 1 qtr
Avantax Planning Partners Inc New 74,321 +74,321 < 0.01% $54,254 1 qtr
UBS Group AG New 42,687 +42,687 < 0.01% $31,162 1 qtr
ARCH Venture Management LLC New 22,102 +22,102 < 0.01% $16,134 1 qtr
GEODE CAPITAL MANAGEMENT LLC New 16,917 +16,917 < 0.01% $12,349 1 qtr
CITADEL ADVISORS LLC New 16,218 +16,218 < 0.01% $11,839 1 qtr
SUSQUEHANNA INTERNATIONAL GROUP LLP New 13,343 +13,343 < 0.01% $9,740 1 qtr
Tower Research Capital LLC TRC New 5,018 +5,018 < 0.01% $3,663 1 qtr
SBI Securities Co Ltd This report Reduced 110 -5,413 < 0.01% $80 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 02, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
110
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.